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ABSTRACT 18 
In this work we are studying if calcium phosphate deposition (CPD) during vascular calcification is a 19 
passive or a cell-mediated mechanism. Passive CPD was studied in fixed vascular smooth muscle cells 20 
(VSMC), which calcify faster than live cells in the presence of 1.8 mM Ca2+ and 2 mM Pi. CPD seems to 21 
be a cell-independent process that depends on the concentration of calcium, phosphate, and hydroxyl 22 
ions, but not on Ca x Pi concentration products, given that deposition is obtained with 2x2 and 4x1 Ca x 23 
Pi mM2 but not with 2x1 or 1x4 Ca x Pi mM2. Incubation with 4 mM Pi without CPD (i.e., plus 1 mM Ca) 24 
does not induce osteogene expression. Increased expression of bone markers such as Bmp2 and Cbfa1 25 
is only observed concomitantly with CPD. Hydroxyapatite is the only crystalline phase in both lysed and 26 
live cells. Lysed cell deposits are highly crystalline while live cell deposits still contain large amounts of 27 
amorphous calcium. High-resolution transmission electron microscopy revealed a nanostructure of 28 
rounded crystallites of 5-10 nm oriented at random in lysed cells, which is compatible with spontaneous 29 
precipitation. The nanostructure in live cells consisted of long fiber crystals, 10-nm thick, embedded in an 30 
amorphous matrix. This structure indicates an active role of cells in the process of hydroxyapatite 31 
crystallization. In conclusion, our data suggest that CPD is a passive phenomenon, which triggers the 32 
osteogenic changes that are involved in the formation of a well organized, calcified crystalline structure. 33 
 34 
Keywords 35 
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INTRODUCTION 39 
Considerable efforts have been made over the last decade to understand the pathogenesis of vascular 40 
calcification (VC). It is now generally accepted that medial mineralization of the arteries (i.e., 41 
Mönckeberg’s sclerosis) is an orchestrated phenomenon that resembles the ossification processes of the 42 
bone (4, 30). The phenomenon includes the transdifferentiation of vascular smooth muscle cells (VSMC) 43 
to a phenotype with osteogenic characteristics as a response to uremic toxins and hyperphosphatemia in 44 
chronic kidney disease (CKD) or in diabetes (9, 17).  45 
Despite the significant amount of knowledge in the field, important questions remain to be answered. For 46 
example, one of the key questions that is still unclear refers to whether calcification is an actively 47 
promoted phenomenon or an actively inhibited phenomenon (27, 28). Regarding the former possibility, 48 
physiological (e.g., bone) and ectopic calcifications take place after the expression of a mineralizing 49 
extracellular matrix (ECM) and after stimulation by hormonal and non-hormonal factors (28). Calcification 50 
is therefore an active process. Regarding the latter possibility, calcification could occur as a consequence 51 
of the absence (bone) or loss (VC) of calcification inhibitors, and therefore calcium phosphate deposition 52 
occurs as a passive phenomenon (28). In this case, mineralization is actively inhibited and prevented in 53 
the arteries under physiological conditions. A key finding that supports the loss-of-inhibition hypothesis of 54 
VC is the observation that a knock-out mouse carrying the VC inhibitor, matrix-Gla protein, shows 55 
extensive calcification of soft tissues, even in the presence of normal blood concentrations of Ca2+ and Pi 56 
(15). This hypothesis is further supported by the fact that the concentrations of Ca2+ and Pi exceed the 57 
solubility product in the extracellular milieu (19), and therefore in the presence of such metastable fluids, 58 
mineralization should start as soon as local calcification inhibitors are eliminated (20). However, the 59 
problem of ectopic calcification can apparently not be explained exclusively by either possibility, given 60 
that the expression of both mineralization activators during VC and the expression of inhibitors under 61 
physiological circumstances have been demonstrated.  62 
One of the key players in the pathogenesis of VC in CKD is Pi, but its specific pathogenic role is still 63 
unclear despite extensive work over the last decade. In this paper we have done an in vitro study of the 64 
pathogenesis of Pi-induced calcification by analyzing the extent of cellular activity involvement during 65 
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initial calcium phosphate deposition (CPD) and by studying the relative role of the osteogenic changes in 66 
the process. We have concluded that while CPD is a passive phenomenon that depends on the absence 67 
of calcification inhibitors, CPD is also responsible for the osteogenic changes that build a biomineralized 68 
deposit with a crystalline nanostructure that is very different from the crystalline nanostructure of passive 69 
mineralization. 70 
71 
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MATERIALS AND METHODS 72 
Cell culture 73 
The isolation and culture conditions of rat aorta VSMC, as well as opossum kidney cells (OK), have been 74 
described previously (37, 38). The protocols were submitted to and approved by the Ethics Committee of 75 
the University of Zaragoza. Cells were grown to confluence and used after an overnight quiescence step. 76 
For calcification, cells were plated in 24-well dishes. VSMC were grown in a minimum essential medium 77 
(MEM), and OK cells were grown in DMEM/F12. Both MEM and DMEM/F:12 were supplemented with 78 
glutamine and 10% fetal calf serum. All cell culture reagents were from Invitrogen (Paisley, UK). For the 79 
preparation of customized (synthetic) MEM (sMEM), the inorganic salt, D-glucose (Dextrose), amino acid, 80 
and vitamin components of the MEM culture medium were obtained separately from Invitrogen. The final 81 
concentrations correspond to the composition of the MEM: 0.814 mM of magnesium sulfate (MgSO4), 82 
5.33 mM of potassium chloride (KCl), 26.19 mM of sodium bicarbonate (NaHCO3), 117.24 mM of sodium 83 
chloride (NaCl), and 1000 mg/L of D-glucose. 84 
Calcification determination 85 
Calcification of VSMC was performed as described, including the preparation and use of lysed cells (39), 86 
except for 24-hour preincubation with 2 mM Pi before lysis, which we found to be unnecessary (see 87 
Results). Both live and fixed cells were calcified in an identical way, and the same calcification medium 88 
was used, which contained 0.5% FCS. In this work, identical results were obtained by paraformaldehyde 89 
fixation and overnight drying. As a negative control, a plate without cells was always used in the 90 
experiments. The calcification of VSMC was identified by Alizarin red staining and was quantified using a 91 
QuantiChromTM Calcium Assay Kit (BioAssay Systems, Hayward, CA).  92 
Collagen and elastin calcification 93 
A rat type I collagen solution was obtained from Invitrogen, and a soluble human elastin, fraction V bovine 94 
albumin, and poly-L-lysine were obtained from Sigma-Aldrich. The collagen, elastin, and albumin were 95 
fixed to a plastic cell culture support at 5 μg/cm2 following the collagen manufacturer’s instructions 96 
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(Invitrogen). The poly-L-lysine coating was applied following the classical protocol for cell culture. 97 
Calcification was then performed as it was for the cells. 98 
Real time PCR 99 
The relative quantification of Msx2, Cbfa1, Bmp2, and SM22 alpha was performed by real-time PCR 100 
using SYBR Green on a LightCycler (Roche Applied Science, Mannheim, Germany), following the 101 
manufacturer’s instructions for calibrator normalized protocols as described (40). The primers used to 102 
amplify Msx2, Cbfa1, and Bmp2 have been listed previously (41). SM22α was amplified using 103 
CAGACTGTTGACCTCTTTGAAG as the upper primer and TCTTATGCTCCTGGGCTTTC as the lower 104 
primer. The acidic ribosomal phosphoprotein (Arp) RNA was used as an endogenous reference (40). 105 
Analysis of calcification composition 106 
The composition, microstructure, and crystal structure of the deposits were characterized by X-ray 107 
powder diffraction (XRD; Rigaku D-max B), scanning electron microscopy (SEM; JEOL 6400) equipped 108 
with an INCA-300 energy dispersive spectroscopy (EDS) system (Oxford Instruments), transmission 109 
electron microscopy (JEOL 2000FXII) equipped with an INCA-200 microanalysis system (Oxford 110 
Instruments), and high-resolution electron microscopy (FEI TECNAI G2 F30). Samples for XRD were 111 
prepared by spreading ground powders on a glass holder. Samples for the structural characterization 112 
were prepared by collecting deposits from 6-well plates for each live and lysed cell cultures and then 113 
mixing them in a mortar. XRD analysis was performed on ground powders spread on a glass holder. For 114 
TEM analysis, powders were dispersed in hexane, and the dispersion was evaporated on a carbon-115 
coated microscope grid. Samples for SEM observations were prepared by gluing pieces of the culture 116 
recipient bottom and coating them with gold or carbon. Part of the samples was washed repeatedly with 117 
water by decantation to eliminate any soluble substance present in the sample before observation.   118 
Data analysis 119 
The mean effective constants of calcification prevention were calculated by non-linear regression, thereby 120 
fitting data to a logarithmic dose-response curve (39). Each experiment was repeated at least three times 121 
with similar results. Data are shown as the mean ± SE. The significances of differences were evaluated 122 
by an analysis of variance and a Tukey’s multicomparison post-test. 123 
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RESULTS 124 
Passive versus active calcium phosphate deposition  125 
We studied passive CPD (i.e., in the absence of any cellular activity or metabolism) using fixed VSMC 126 
(39). In this case, we did not preincubate the cells with 2 mM Pi for 24 hours before lysis, as initially 127 
described (39), because we found that dead cells calcified to the same extent, whether or not the cells 128 
were subjected to this previous treatment (data not shown).  We compared the amount of CPD obtained 129 
using either live or fixed VSMC in the presence of a culture medium (MEM) containing 2 mM Pi (Fig. 1A). 130 
Calcium deposition increased significantly in fixed cells (black bars) after 3 days and significantly in live 131 
cells (open bars) after 5 days. At 3, 5, and 7 days, the amount of precipitated Ca2+ in fixed cells was three 132 
times the amount in live cells. This difference was then kinetically analyzed by comparing the dose-133 
response effects of pyrophosphate on the prevention of calcification in both live and fixed cells (Fig. 1B). 134 
The Hill slopes of the curves were similar (-2.4 vs. -2.7 for live and fixed cells, respectively), but the ECs50 135 
of PPi were very different: 2.6 and 8.8 µM for live and fixed cells, respectively. Therefore, more PPi is 136 
necessary to prevent calcification in fixed cells. Subtraction of both logarithmic curves provided a log 137 
normal distribution curve with a mean of 4.9 ± 1.0 µM and a standard deviation equivalent to the Hill-1 138 
slope (2.14). Several interpretations can explain the shift in EC50, but it is most likely due to the amount of 139 
calcification inhibitors, such as PPi, which are produced by live cells and are missing in fixed cells. Similar 140 
findings were obtained in our previous work using bisphosphonates (39).  141 
Next, we attempted to define the nature of the macromolecular matrix required for CPD and adsorption in 142 
the cells. VSMC were incubated in MEM with 2 mM Pi for up to 5 days (Fig. 2A), and every day a group of 143 
cells were trypsinized or lysed with the indicated detergents at 0.1%. The wells were then kept in the 2 144 
mM Pi medium for the remaining days. The cells that were lysed with any of the three detergents calcified 145 
at the same intensity as from the first day of lysis. This suggests that calcification takes place 146 
predominantly in the protein phase of the cells, but a role by the lipid component cannot be excluded. Fig. 147 
2B shows the calcium quantification after 7 days of incubation with 1 or 2 mM Pi, according to the 148 
indicated treatments. 149 
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Next, we directly studied the role of collagen and elastin, two extracellular proteins that are known to 150 
induce calcification. Rat collagen type I and human elastin were fixed onto cell culture plates and 151 
incubated with MEM containing either 1 or 2 mM Pi for seven days. Staining with Alizarin red revealed an 152 
intense calcification of all collagen fibers incubated with 2 mM Pi, as well as intense calcification of the 153 
globular elastin that was attached to the plastic surface, which concurs with previous in vitro and in vivo 154 
studies (Fig. 2C). Surface coating with albumin or poly-L-lysine did not induce CPD in the culture dishes. 155 
These results indicate that calcification can apparently be obtained with single molecules when specific 156 
experimental conditions are attained. However, as shown below, the definite crystal ultrastructure is only 157 
obtained when the active cell is present.  158 
Role of the composition of the cell culture medium and of pH 159 
In vitro calcification of VSMC is an established model of VC that, in some cases, has yielded significant 160 
differences in calcification rates among laboratories, as demonstrated by the use of different Pi 161 
concentrations (usually 2-4 mM Pi) in culture media to induce Pi-related VC. Therefore, before continuing 162 
with subsequent experiments, we checked to see if the composition of the different culture media could 163 
be at least partially responsible for these differences. We obtained identical qualitative results using either 164 
live or lysed cells. VSMC were induced to calcify using 2 mM Pi by supplementing the phosphate 165 
concentration of three different culture media: MEM, DMEM, and DMEM/F:12. Figure 3A shows that the 166 
calcification induced using 2 mM Pi (black bars) was only obtained with MEM or DMEM, while cells 167 
incubated with DMEM/F:12 did not calcify. Comparison of the media revealed that MEM and DMEM 168 
contain 1.8 mM Ca2+, while DMEM/F:12 contains only 1.05 mM. DMEM/F:12 was subsequently 169 
supplemented to reach a final concentration of 1.8 mM Ca2+, after which calcification was successfully 170 
induced using 2 mM Pi (Fig. 3B) at pH 7.5 or higher (pH 8.0). In this study we only used fixed VSMC to 171 
maintain a constant pH. No calcification was observed at pH 7.0 or in cells incubated using 1 mM Pi at 172 
any of the three pHs. Therefore, while VSMC cultures can be a valuable model for studying cell-mediated 173 
calcification, it is essential to observe standardized experimental conditions and the use of similar culture 174 
media. In any event, this finding does not invalidate the knowledge obtained with these cultures during 175 
the last decade. 176 
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While the effect of pH on calcification has been extensively studied, we nevertheless performed an 177 
additional experiment to understand the pathogenesis of CPD. Opossum Kidney (OK) cells constitute a 178 
proximal tubular cell line that is known to quickly acidify culture medium, even below pH 7.0. 179 
Consequently, when OK cells were incubated with DMEM/F:12 (the usual culture medium) containing 1.8 180 
mM Ca2+ and 2 mM Pi, they did not calcify (Figure 3C). In contrast, when we used fixed OK cells, the pH 181 
did not change and calcification occurred at a rate similar to the VSMC rate. While there are other 182 
possibilities in addition to pH, such as the presence of calcification inhibitors, this finding suggests that the 183 
expression of a specific extracellular matrix is not necessary to initiate CPD and that calcification will take 184 
place in any cell in the absence of anticalcifying agents such as pyrophosphate or an acidic milieu.  185 
Effects of pH and Ca x Pi products on in vitro calcification 186 
Apart from pH, the Ca x Pi concentration product is another parameter that affects calcification, and while 187 
it is generally considered to be a risk factor in hemodialysis patients, there is also growing controversy 188 
about its significance (19). We studied the validity of this parameter using the passive CPD model, 189 
because fixed VSMC allow the use of a supraphysiological concentration of Ca2+ and Pi. VSMC were 190 
incubated for six days in a DMEM/F:12 medium supplemented with different concentrations of Ca2+ and 191 
Pi (1, 2, or 4 mM, Fig. 3D). No calcification was observed when the Ca x Pi molar product was kept below 192 
4 mM, in any combination. Calcification was observed when a 4 mM Ca x Pi product was obtained by 193 
combining 2 mM Ca2+ and 2 mM Pi, or 4 mM Ca2+ and 1 mM Pi. No calcification was observed when the 194 
4 mM Ca x Pi product was obtained with 1 mM Ca2+ and 4 mM Pi.  195 
These results point to a predominant role of Ca2+ over Pi during calcification, as it has been reported 196 
previously (42) and very recently while our work was under review (33). A more detailed analysis of the 197 
calcium effect was studied on fixed VSMC so that non-physiological concentrations of Ca and Pi could be 198 
used. VSMC were incubated in the presence of a constant concentration of 1 mM Pi, with increasing 199 
concentrations of Ca2+ (Fig. 4A). Under these conditions, no saturation was obtained, but calcification 200 
increased with the increasing Ca2+ concentration. Conversely, when the concentration of Ca2+ was fixed 201 
at 1.5, 1.8, or 2.0 mM, the calcification obtained by increasing the concentration of Pi was saturated 202 
(maximal) at 3 mM Pi and 2 mM Ca2+ (Fig. 4B). The predominance of Ca2+ over Pi can be explained in 203 
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physiochemical terms (see Discussion), considering that the cells were lysed and therefore any effect by 204 
calcium signaling can be discarded. 205 
Calcifying components of the culture medium 206 
Based on the varying extent of the calcification obtained using the different basal culture media and the 207 
dependence of calcification on the calcium content, we attempted to determine the involvement of the 208 
other components of the culture media in in vitro calcification.  We once again used lysed VSMC so that 209 
non-physiological conditions could be used in the experiments. Cells were incubated in MEM or in the 210 
different components of this basal medium, supplemented (or not) with phosphate to finally obtain 2 mM 211 
Pi. When the following components were combined, a synthetic MEM (sMEM) was obtained, as explained 212 
in Methods: a salt component (SC) and SC plus amino acids, vitamins, or glucose (Fig. 4C). In the 213 
presence of 2 mM Pi, calcifications were observed in all combinations, and the addition of amino acids 214 
and vitamins did not alter the extent of calcification. The involvement of the MEM salt component in 215 
calcification was further analyzed by combining the various components and by incubating fixed VSMC 216 
for six days using 1.8 mM Ca2+ plus 2 mM Pi (Fig. 4D). NaCl, KCl, and MgSO4, either individually or 217 
combined, reduced the deposition of calcium induced with Ca and Pi. Conversely, the bicarbonate ion 218 
increased calcium deposition as expected, independently of any other ion present in the medium. The pH 219 
of the medium was kept at a constant 7.4 using 10 mM Hepes-Tris, and it was checked using a pH-meter. 220 
In summary, choosing the correct culture medium is a critical factor when performing in vitro calcification 221 
assays. 222 
Calcium phosphate deposition induces osteogenic changes 223 
The preceding findings on CPD and Ca x Pi products led us to compare the effects of different conditions 224 
on osteogene expression and on the transdifferentiation of VSMC during calcification. Specifically, we 225 
could now study the effects of CPD on osteogene expression separately from the effects of a high Pi 226 
concentration on osteogene expression. VSMC were incubated for 24 hours with MEM containing 1.8 mM 227 
Ca2+, plus either 1 or 2 mM Pi, and then the abundance of Bmp2, Cbfa1, Msx2, and Osx was determined 228 
by using real-time PCR. Fig. 5A shows that, after just one day of incubation, the expression of Cbfa1, 229 
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Msx2, and Osx was significantly increased. The abundance increased thereafter (including Bmp2), and it 230 
was very strong after 5 days (Fig. 5B), when calcification was very intense (see Fig. 1A).  231 
For a more detailed analysis of the effects of Ca x P, different combinations of Ca2+ and Pi were used to 232 
study the osteogene expression response in VSMC (Fig. 5C). VSMC were incubated for three days in 233 
sMEM in the presence of either 2 mM Ca2+ plus 1 mM Pi, 2 mM Ca2+ plus 2 mM Pi, 1 mM Ca2+ plus 4 mM 234 
Pi, or 4 mM Ca2+ plus 1 mM Pi. The combinations that induced calcification (2 mM Ca2+ plus 2 mM Pi and 235 
4 mM Ca2+ plus 1 mM Pi) were the only ones to increase the abundance of Bmp2 and Cbfa1, while the 236 
expression of the smooth muscle marker SM22α decreased. When the concentration of Pi was increased 237 
to 4 mM and the concentration of Ca2+ was decreased to 1 mM to avoid calcification (see Fig. 3D), no 238 
significant changes in the abundances of Cbfa1, Bmp2, or SM22α were observed compared to the control 239 
(2 mM Ca2+ plus 1 mM Pi). These findings demonstrate that the increased extracellular concentration of 240 
Pi is not responsible for changes in osteogene expression in VSMC, but rather the initial deposition of 241 
calcium phosphates is responsible for the changes. 242 
Analysis of calcium phosphate deposits 243 
The calcifications obtained in live and lysed cells were analyzed to check whether the final composition of 244 
the mineralization process (i.e., after CPD) was similar in both situations. Significant differences between 245 
the compositions in both experimental situations would indicate the active involvement of 246 
transdifferentiated cells in the process. The crystal structure of deposits of live and fixed cells were 247 
analyzed by x-ray powder diffraction. XRD patterns from live and fixed samples showed narrow peaks 248 
corresponding to a halite structure (NaCl). Patterns of samples after washing are shown in Fig. 6A. The 249 
broad band centered at 22o arises from the glass holder. The rest of the peaks correspond to nanometric 250 
crystals, and they can be indexed according to an apatite crystal structure, in both live and lysed VSMC. 251 
The composition and microstructure of the deposits in live and lysed VSMC were analyzed by SEM (Fig. 252 
6B and C). The surface of the deposits was flat, especially in living cell cultures, and it was formed by 253 
compact arrangements of spherolite-shaped particles.  254 
EDS analyses showed the presence of P, Ca, Mg, Cl, and Na in both live and lysed cell samples. 255 
However, the Ca/P atomic ratios were different in lysed and live cell deposits. In lysed cells the Ca/P ratio 256 
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was close to 1.7 (mean = 1.72, SD = 0.16), which is the ratio corresponding to the hydroxyapatite 257 
compound (Ca10(PO4)6(OH)2) and which explains the presence of the Mg that is often found in this 258 
compound. In live cells this ratio significantly decreased (mean = 1.40, SD = 0.21), whereas the O/P ratio 259 
increased, indicating the presence of calcium-deficient compounds with a high degree of hydration [such 260 
as amorphous calcium phosphate (Ca9(PO4)6·nH2O; Ca/P = 1.5, O/P = 4.8), octacalcium phosphate 261 
(Ca8H2(PO4)6·5H2O; Ca/P = 1.33, O/P = 4.8), and dicalcium phosphate dihydrate or brushite 262 
(CaHPO4·2H2O; Ca/P = 1.0, O/P = 6.0)] (16). The absence of these compounds in XRD patterns can be 263 
due to their amorphous character or to a small crystallite size.  264 
Ultrastructural analysis of crystallites 265 
A more detailed view of the microstructure was obtained by TEM and high-resolution TEM (HRTEM). 266 
Images at low resolution show planar formations in both types of deposits (Figs. 7A and 7C). However, 267 
high-resolution observations revealed that these formations are polycrystalline and that they have a very 268 
different degree of crystallization and crystallite shape in the deposits of live versus lysed cells. The insets 269 
of panels A and C are at higher magnifications and show granular and fibrillar structures, respectively. 270 
The nanostructure in lysed cell deposits consists of highly crystalline regions with a size of 5 to 10 nm and 271 
a rounded shape (Fig. 7B). However, live cells showed an amorphous or poorly crystalline background, 272 
which is crossed by long filaments that have well-defined crystal planes and a thickness of about 10 nm.  273 
The orientation of the crystallites within the sheets was analyzed by direct measurement of the interplanar 274 
distances on atomic resolution HRTEM images and by Fast Fourier Transform (FFT) diffraction patterns 275 
from the images. Crystallites in lysed cell samples yielded 7 different dhkl distances corresponding to the 276 
(300), (002), (112), (210), (211), (222), and (300) crystal planes of hydroxyapatite. All these planes were 277 
observed on FFT patterns (Fig 8A) that also showed 10 extra reflections that could be assigned to 278 
hydroxyapatite crystal structure. It is therefore apparent that hydroxyapatite is the only crystalline phase in 279 
the samples and that the crystallites are oriented at random with respect to the sheet plane. In live cell 280 
samples, the distances measured between planes parallel to the direction of elongation of the fiber-281 
crystals were mainly close to 3.42 Å, which corresponds to d002 in hydroxyapatite (3.45 Å), although in 282 
some defected crystals the distance was slightly larger (up to 3.9 Å). Therefore, the direction of 283 
elongation of the fiber-crystals is perpendicular to [001]. This reflection was also present in all the FFT 284 
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patterns taken on both single-crystal and polycrystalline regions (Fig. 8B). FFT patterns showed an extra 285 
reflection at 2.07 ± 0.04 Å, forming an angle of nearly 30o with the (001) reflection that could be assigned 286 
to d113 in hydroxyapatite (2.07 Å). Therefore, the crystals are oriented with their [-110] direction parallel to 287 
the electron beam, and they are elongated along the [110] direction. Apart from the amorphous 288 
background and the fiber-crystals, HRTEM images of lysed cell samples showed areas with bent parallel 289 
grooves, as shown in Fig. 8C, that could be interpreted as intermediate stages of crystallization.  290 
 291 
 292 
 293 
 294 
295 
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DISCUSSION 296 
Medial vascular calcification is a degenerative disease that is highly prevalent among patients who are on 297 
hemodialysis or who have diabetes. Recently, many characteristics of ossified arteries have been 298 
described, including the activation of a transdifferentiation program of VSMC into cells with osteoblast-like 299 
properties and the expression of a calcifying ECM. Nevertheless, neither the pathogenic steps during VC 300 
nor the specific roles of some of the agents that are clearly involved (hyperphosphatemia, uremia, 301 
hyperglycemia, and aging) have yet to be fully understood (for reviews of these subjects see references 302 
3, 5, 11, 14, 15, and 17). 303 
For example, it is still unclear whether VC is an active degenerative process or, conversely, it is a passive 304 
phenomenon that the tissue attempts to control. In this work we have aimed to clarify this point by using 305 
lysed VSMC as a simple model of passive calcification. Our findings point to an intermediate possibility: 306 
CPD is a passive phenomenon that seems to take place when the abundance of calcification inhibitors 307 
are decreased, and this adsorption to the cells is a major step that initiates specific osteogene expression 308 
and trans-differentiation of VSMC into osteoblast-like cells. Such osteogenic changes seem to be 309 
responsible for the organized apatite crystal ultrastructure, which consists of an amorphous crystalline 310 
background crossed by long, fibrillar crystal planes.  311 
Role of initial calcium phosphate deposition 312 
Our conclusion that CPD is a passive phenomenon is based on several results. First, we have found that 313 
lysed VSMC calcify faster than live cells when they are incubated with 2 mM Pi in a MEM culture medium 314 
(Fig. 1). One new fact that we have unveiled is that it is not necessary to incubate live cells with 2 mM Pi 315 
for 24 hours before lysis so that they calcify after lysis (39). This finding means that the induction of 316 
calcifying genes and the formation of a specific ECM (i.e., calcification activators) are not requisites for 317 
the initial step in VC, i.e., calcium phosphate deposition. Under these in vitro conditions, it is necessary to 318 
add more PPi to lysed cells than to live cells in order to prevent Pi-induced calcification (Fig. 1B). This 319 
finding can be interpreted, but not exclusively, as the inability of lysed cells to produce calcification 320 
inhibitors (pyrophosphate, triphosphate, and other polyphosphates), wherefore additional PPi must be 321 
added during the assay to prevent calcification. As a whole, the finding that the induction of specific 322 
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calcification activators (i.e., specific osteogenes) is not necessary to initiate the calcification process, and 323 
that additional PPi is necessary in lysed cells to prevent calcification agrees with and supports the loss-of-324 
inhibitors hypothesis of VC.  325 
Additional results in this study also support the view that CPD is a passive phenomenon. CPD can simply 326 
start after combining a few components of the MEM cell culture medium. As shown in Fig. 4D, the calcium 327 
deposition obtained with 1.8 mM Ca2+ plus 2 mM Pi in water is decreased by the presence of Na+, K+, and 328 
Mg2+ ions in the assay, but it is increased with the addition of a bicarbonate ion. The Na+, K+, and Mg2+ 329 
ions can play a role in the onset of calcification, because several ion substitutions have been described 330 
regarding hydroxyapatite (Ca10(PO4)6(OH)2): Mg2+, Sr2+, Pb2+, or Na+ for Ca2+; carbonate or arsenate for 331 
phosphate; and F- or Cl- for OH- (10). Therefore, in the calcification process each of these ions will 332 
determine the formation and final composition of calcium-phosphate deposits, and when calcification 333 
inhibitors or an acidic pH are neutralized, CPD will even start in non-VSMC (e.g., renal OK cells; Fig. 3C). 334 
Deposition depends on many other factors, but only minimally on the calcium-phosphate concentration 335 
product (19). In blood, while Ca and Pi concentrations exceed the solubility product for hydroxyapatite, 336 
these concentrations are not supersaturated, because blood composition is very complex: other ions and 337 
proteins are involved in solubility and deposition. In a quiescent in vitro model of VSMC, media 338 
composition is not as complex. Nevertheless, we have confirmed that this is also not a valid parameter in 339 
vitro, because the product of 4 mM2 (Ca x P) is only critical when calcium is present at ≥ 2 mM and 340 
because a medium containing 1 mM Ca and 4 mM Pi does not result in calcium-phosphate deposition 341 
(Fig. 3D). This is based on calcium’s predominant role over Pi (Fig. 4A and B) and on the relevance of 342 
hydroxyl ions (Fig. 4D) during calcium-phosphate deposition, which concurs with previous calcification 343 
studies (28) and with some works showing that hydroxyapatite is synthesized from brushite or 344 
octacalcium by adding calcium and hydroxyl ions (3, 16).  345 
Another remarkable finding in this work is that the induction of osteogene expression and the 346 
transdifferentiation of VSMC in vitro are not caused by high Pi levels in culture media such as those 347 
observed during hyperphosphatemia, but rather they are caused by CPD. As shown in Fig. 3D, we have 348 
been able to increase the Pi concentration up to 4 mM without calcium phosphate deposition simply by 349 
reducing the calcium concentration to 1 mM. Under these conditions, no calcification was observed, the 350 
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expressions of Bmp2 and Cbfa1 were not induced, and there was no change in the abundance of the 351 
smooth muscle marker Sm22α (Fig. 5C). The expression of Bmp2 and Cbfa1 and the inhibition of Sm22α 352 
only occur concomitantly with CPD. This finding implies that not only does CPD precede changes in the 353 
osteogene expression characteristic of VC but also that deposition itself, rather than the concentrations of 354 
free Pi in the cell culture, is most likely responsible for the changes in gene expression and for the 355 
transdifferentiation of this in vitro model. These findings concur with previous studies that prevented Pi-356 
induced osteogene expression using PFA (2, 11). The results had been interpreted as the inability of Pi to 357 
enter the cell and induce gene expression. However, considering that PFA is not an inhibitor of VSMC Pi 358 
transport but rather an inhibitor of CPD (39), those previous results (2, 11) can be now reinterpreted, 359 
because they suggest that osteogene expression is caused by calcium phosphate deposition. Our 360 
findings also agree with previous proposals of Prof. Shanahan, who suggested that calcium-induced 361 
microcalcifications in sites of apoptosis precedes the osteogenic differentiation of VSMC, and that this 362 
could be a universal initiation mechanism for both medial and intimal calcification (32).  363 
Ultrastructural analysis of calcification crystals 364 
While the initial steps in ectopic calcification (i.e., CPD) seem to constitute a passive phenomenon, an 365 
analysis of the calcification crystal structure has revealed that cells participate actively in the final 366 
outcome, because there are a series of important differences between the composition and structure of 367 
the calcification deposits in lysed and (metabolically active) live cells (Figs. 7-8). In both cases, however, 368 
apatite is the predominant phosphate crystalline compound, and at a micrometer level, deposits are 369 
composed of polycrystalline planar formations. Hydroxyapatite (Ca10(PO4)6(OH)2) is the most stable 370 
calcium phosphate phase, and it is the most frequent one in geological and biological mineralizations (5, 371 
43). It precipitates directly only when the calcium phosphate ionic product is above the hydroxyapatite 372 
saturation point, but below the saturation point of intermediate CaP phases, such as octacalcium 373 
phosphate (OCP, Ca8H2(PO4)6.5H2O). Otherwise, the hydroxyapatite formation process occurs after an 374 
initial precipitating phase of amorphous calcium phosphate, which has a low Ca/P ratio (1.5) and consists 375 
of Ca9(PO4)6 clusters (Polner’s cluster) arranged in low density fractal aggregates (31). These aggregates 376 
are gradually ordered into a crystalline hydroxyapatite structure with a Ca/P ratio of 1.68. This process 377 
can be very slow, especially in biological systems (5,43), but it can be accelerated by high Ca/P ratios 378 
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and a high pH. The theoretical equilibrium morphology of hydroxyapatite crystals consists of a {101} 379 
bipyramid with {100} prismatic lateral faces and {103} and {111} faces at the corners (6). However, the 380 
real morphology of crystals grown at nearly equilibrium conditions is that of hexagonal prisms bounded by 381 
{100} side faces, with elongation in the [001] direction (24, 35). Given that the solubility of hydroxyapatite 382 
in water is very low, crystal growth in aqueous solutions is usually far from equilibrium conditions. 383 
Consequently, critical supersaturation for nucleation is very high, the nucleation rate is also very high, and 384 
the crystal growth rate is very low. Thus, unless special methods are used, such as hydrothermal or slow 385 
diffusion, the morphology of hydroxyapatite crystals grown in aqueous media is far from the equilibrium 386 
morphology. Typical hydroxyapatite aqueous precipitates consist of spherulitic agglomerates of a) non-387 
faceted needle crystals elongated along the [001] direction when the pH is abruptly increased  (26) or b) 388 
(100) platy crystals for slow pH increase (12). Fast growth conditions favor a needle-like morphology (23), 389 
and crystallization from intermediate phases favor a planar morphology (43). Biomimetic hydroxyapatite 390 
precipitates also show spherulitic formations of platy crystals elongated along [001] (18). In physiological 391 
calcium phosphate biomineralizations (i.e., bones and teeth), the main phase is hydroxyapatite, although 392 
they may contain other intermediate phases (especially in bones). The main feature that distinguishes 393 
physiological crystallizations from pathological ones is that the particles are hierarchically ordered thanks 394 
to the templating effect of organic matrixes (14, 44). In pathological calcifications, hierarchical order is 395 
lost, although some texturing produced by the presence of an organic matrix is usually found. The same 396 
thing occurs in aortic calcifications, which show a stratified microstructure of concentric, inorganic layers 397 
bounded by an organic matrix (1, 8, 21, 29). The hydroxyapatite crystals are planar and are arranged in 398 
spherulitic formations. The crystallite size, around 2-10 nm, is much smaller than in physiological 399 
calcifications.  400 
In our experiments of live vs. dead cell calcification, there are considerable differences in the crystal 401 
structure. CaP deposits from lysed cells show a hydroxyapatite atomic structure, a slight presence of 402 
amorphous calcium phosphate, a high Ca/P ratio (~1.7), spherulitic arrangements of platelets, a rounded 403 
crystallite shape, and a crystallite size of around 5 nm. Moreover, there is no preferential growth direction 404 
or oriented crystallite assembly. This structure is similar to the structure found in aortic calcifications at 405 
atomic/nanometric and microscopic levels, apart from the presence of organic matrix in aortic 406 
18 
 
 
calcifications. For example, studies of calcifications in the iliac arteries of patients with uremia showed the 407 
presence of spherullites and a microstructure of planar formations composed of rounded nanocrystals 408 
with a size of 2 to 10 nm (29). The crystalline phase in the referenced study was mostly apatite, together 409 
with whitlockite, which was only detected by using a very intense x-ray source such as synchrotron 410 
radiation. This crystallite structure is also found in spontaneous calcium phosphate precipitations, and it 411 
can therefore be produced without the intervention of foreign substances. The structure of the deposits 412 
gives some clues about the precipitation conditions. The small crystallite size suggests intense nucleation 413 
and short crystal growth periods; the planar shape is consistent with crystallization from amorphous 414 
calcium phosphate precursors; and the high Ca/P ratio indicates a complete amorphous calcium 415 
phosphate to hydroxyapatite conversion. Live cell deposits show similar macroscopic and microscopic 416 
structures. However, at atomic and nanometric levels, there are significant differences: amorphous 417 
calcium phosphate is present in large amounts, the Ca/P ratio is low (~ 1.4), and crystalline domains are 418 
strikingly fiber-shaped. Elongated crystals are found in synthetic crystals of various sizes and are very 419 
common in physiological biomineralizations. However, the direction of elongation is usually the [001], 420 
while here the fibers are elongated along the perpendicular direction (apparently the [110] direction). 421 
Moreover, regarding enamel, rod crystals are formed by a templated assembly of spherical crystals 422 
induced by the amel protein (44), whereas here the elongated shape appears at the very first instance of 423 
nucleation. In fact, the presence of bent grooves suggests the intervention of flexible organic 424 
macromolecules that self-assemble with Polner’s clusters, thereby forcing the alignment of these clusters 425 
and the formation of fibrillar nuclei. Furthermore, as shown in Fig. 1, the total amount of deposited mineral 426 
is substantially less in live cells than in lysed cells. On the other hand, the presence of other hydrated 427 
calcium phosphate species in live cells, in addition to apatite, contradicts previous in vitro works (11) but 428 
agrees with some in vivo studies (13, 29, 36). These hydrated species are deficient in Ca2+ but rich in 429 
oxygen, thereby resulting in a Ca/Pi index of about 1.4, and they can be considered to be hydroxyapatite 430 
precursors (7, 10). This indicates that the crystallization process in live cells is at an early stage, most 431 
likely as a consequence of a reaction by cells to avoid calcification. Indeed, VSMC cells can reduce the 432 
free calcium content in the medium by several mechanisms. For instance, they can do so through the 433 
matrix-Gla protein (MGP), which acts as a local calcification inhibitor by calcium sequestration (15). In 434 
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addition, the expressions of transient receptor potential calcium channels (TRPCs) and of vanilloid 435 
receptor channels (TRPVs) can assist in this process. In conclusion, live cells have a strong influence on 436 
CaP crystallization in three ways: 1) by reducing the precipitation rate, 2) by restraining the amorphous 437 
calcium phosphate to hydroxyapatite conversion, and 3) by templating the crystal nucleation process. 438 
Promoters, inhibitors, and templates of crystallization are omnipresent in physiological and pathological 439 
biomineralization processes (7, 8, 22, 25, 34). In fact, normal human serum is supersaturated with 440 
respect to hydroxyapatite, OCP, and carbonate apatite, but normal vascular cells have the capacity to 441 
inhibit CaP precipitation (8). Actually, the role of inhibitors in preventing mineralization in noncalcifying 442 
tissues is generally assumed (22), whereas the lack of inhibitors is considered an important risk factor for 443 
pathological calcifications (34). There may be several types of substances that induce the changes to 444 
hydroxyapatite crystallization observed in live cell deposits.  Effects 1) and 2) can be produced by calcium 445 
ligands such as citrate or pyrophosphate or by macromolecules containing carboxylate, sulfate, or 446 
phosphate residues.  However, effect 3) requires a high templating capacity that is usually exerted by 447 
proteins such as collagen, elastin, osteopontin, etc. 448 
In summary, our data point to an intermediate scheme in the calcification process, i.e., between the loss-449 
of-inhibitors hypothesis and the view that calcification is an active, orchestrated process. While calcium 450 
phosphate deposition seems to be a passive phenomenon starting with the local loss of calcification 451 
inhibitors, CPD actually induces the expression of key osteogenes that modulate the biomineralization of 452 
the ECM in a specific crystalline structure. Several important questions, however, remain to be answered. 453 
For example, we need to decipher the mechanisms that lead to the initial deposition of calcium 454 
phosphates and the loss of local inhibitors that seem to precede calcification. In addition, further research 455 
is necessary to make a detailed comparison of the crystallite structure of in vitro and in vivo aortic VSMC 456 
calcification, at a resolution that is at least as high as the one used in this study. Similarly, it is also 457 
necessary to understand the specific roles that osteogenes play in the calcification process, because the 458 
difference between dead or metabolically active (live) cells is only related to the ultrastructure of the 459 
nascent crystals. Cells prevent calcification through the production of potent inhibitors (e.g., Fig. 1), while 460 
at the same time they can express specific osteogenes as a response to CPD. Only osteogene-specific 461 
deletion will help to understand this apparent dichotomy, but at present active prevention of calcification 462 
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with inhibitors seems to play an initial and mandatory, key role in the process. For example, gene deletion 463 
of the local inhibitor MGP induces calcification in arteries under homeostatic Pi conditions (15), and VC is 464 
also observed under normal Pi concentrations if other uremic toxins are present (17). Therefore, even 465 
under normal Ca and Pi concentrations, CPD seems to be an inevitable phenomenon over time, which 466 
arteries attempt to prevent by using mechanisms that need to be deciphered. Whether osteogene 467 
expression plays an active role in the pathogenesis of vascular calcification or, conversely, it is only a 468 
non-pathological response to CPD, is a point of debate that needs to be definitively clarified.  469 
 470 
471 
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FIGURES 585 
Figure 1. Calcification of VSMC in vitro. A. Incubation of live (open bars) and fixed (black bars, 3% 586 
paraformaldehyde) VSMC with MEM containing 2 mM Pi, for the indicated times. B. Kinetic analysis of the 587 
effect of PPi on the calcification of live cells (squares) and fixed cells (triangles), showing fits to sigmoidal, 588 
dose-response curves. The subtraction of both curves provides a Gaussian fit (bold line). *Significantly 589 
different from the corresponding value at 1 day.  590 
Figure 2. Proteins involved in vascular calcification. A. Effect of detergents on cells incubated with 2 mM 591 
Pi for up to 5 days. Every day a group of cells were either trypsinized or treated with the indicated 592 
detergents and saponine, all of them at 0.1 %. Calcification was visualized with alizarin red. B. 593 
Quantification of the calcium content in cells treated as indicated during seven days in MEM with 2 mM 594 
Pi.  C. Alizarin red staining of collagen I, elastin, albumin or poly-L-lysine attached to a plastic support and 595 
incubated with 1 or 2 mM for seven days. 596 
Figure 3. Effect of cell culture composition, pH and Ca x P products. A. Effect of 2 mM Pi on the 597 
calcification of fixed VSMC using MEM, DMEM, and DMEM/F:12. B. Effect of pH on 2 mM Pi-induced 598 
calcification in lysed VSMC cells using DMEM/F:12, supplemented to contain 1.8 mM CaCl2. C. 599 
Calcification using DMEM/F:12 with 2 mM Pi in live (open bars) and fixed (black bars) OK cells for the 600 
indicated times. D. Calcification takes place when Ca x Pi products are obtained with 2x2 or 4x1 mM Ca x 601 
Pi. Cells were fixed with 3% paraformaldehyde. 602 
Figure 4. Role of calcium and media components on calcification. A. Calcification of fixed VSMC with 603 
increasing concentrations of Ca2+ and a constant Pi (1 mM). Cells were fixed with 3% paraformaldehyde. 604 
B. Calcification induced with increasing concentrations of Pi, at three fixed concentrations of Ca2+: 1.5, 605 
1.8, and 2 mM. C. Effect of MEM components on Pi-induced calcification: aa+vit, amino acids plus 606 
vitamins; SC, salt component; Glc, glucose. D. Analysis of the effect of the salt component of MEM 607 
culture media on Pi-induced calcification in VSMC.  608 
Figure 5. Osteogene RNA expression during calcification. A. Expression of Bmp2, Cbfa1, Msx2, and Osx 609 
in VSMC incubated with sMEM for 24 hours with 1.8 mM Ca2+ plus 1 or 2 mM Pi. B. Expression of the four 610 
genes as a function of the number of days of treatment with 2 mM Pi. *Significantly different from the 611 
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corresponding 1 mM Pi (p < 0.05). C. Expression of Cbfa1, Bmp2, and Sm22α in the presence of the 612 
indicated combinations of Ca2+ and Pi, in mM, for three days. Cbfa1 and Bmp2 are only induced when the 613 
combination of Ca2+ and Pi leads to CPD, as shown in Fig. 2D. *Significantly different from 2 mM Ca2++1 614 
mM Pi (p<0.05). 615 
Figure 6. Analysis of the crystal composition in mineralized live and lysed cells. A. XRD patterns of lysed 616 
and live powdered deposit samples; bars correspond to the hydroxyapatite crystal structure. B and C, 617 
SEM images or deposits from lysed (B) and live (C) cell cultures. Cells were lysed with 3% 618 
paraformaldehyde. 619 
Figure 7. Transmission electron microscopy analysis of crystalline domains. A and C, deposits of lysed 620 
and live cells; insets show higher magnification revealing granular and fibrillar structures, respectively. B 621 
and D, HRTEM images of lysed and live cell deposits, showing the difference between rounded 622 
crystalline domains in lysed cells and long fibers in live cells. Cells were lysed with 3% paraformaldehyde. 623 
Figure 8. Fast Fourier transform of atomic resolution HRTEM images of (A) a polycrystalline area from a 624 
lysed cell deposit sample; and (B) a fiber-nanocrystal from a live cell deposit sample. C. HRTEM image of 625 
an area of a live cell deposit sample showing parallel bent grooves that can be interpreted as an 626 
intermediate stage of fiber-crystal formation process. 627 
 628 








